FrancophonIA/ELRC3.0 huggingface dataset:
English: Didanosine is intended to be administrated on en empty stomach as stated in the proposed Summary of Product Characteristics (SmPC): “Didanosine absorption is reduced in the presence of food, and hence Didanosine gastro-resistant capsules should be administrated on an empty stomach (at least 2 hours before or 2 hours after a meal)”.
Slovenian: • Priporočila za odmerjanje didanozina Didanozin je namenjen zaužitju na prazen želodec, kot je navedeno v predlaganem povzetku glavnih značilnosti zdravila: „Ker se absorpcija didanozina v prisotnosti hrane zmanjša, je treba gastrorezistentne kapsule zdravila Didanosine zaužiti na prazen želodec (vsaj 2 uri pred obrokom oz. 2 uri po njem)“.
English: 7 Perry CM, Balfour JA. Didanosine: An Update on its Antiviral Activity, Pharmacokinetic Properties and Therapeutic
Slovenian: Perry CM, Balfour JA. Didanosine: An Update on its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Efficacy in the Management of HIV Disease.
English: Background
Slovenian: Podlaga
English: In viral nucleic acid replication, incorporation of this 2', 3'-dideoxynucleoside prevents chain extension, and thereby inhibits viral replication.
Slovenian: Med replikacijo virusne nukleinske kisline vgradnja tega 2', 3'-dideoksinukleozida prepreči podaljševanje verige in tako zavre replikacijo virusa.
English: After didanosine enters the cell, it is enzymatically converted to dideoxyadenosine-triphosphate (ddATP), its active metabolite.
Slovenian: Po vstopu v celico se didanozin encimsko pretvori v dideoksiadenozin-trifosfat (ddATP), ki je njegov aktivni presnovek.
English: The presented data does not give evidence of in vivo dose-dumping from the formulation under fed conditions.
Slovenian: Predstavljeni podatki ne dokazujejo in-vivo sprostitve celotnega odmerka naenkrat iz formulacij pri zaužitju po obroku.
English: Chicago 2001 La Porte C et al. Pharmacokinetic interaction study of indinavir/ritonavir and the enteric-coated capsule formulation of didanosine in healthy volunteers.
Slovenian: La Porte C et al. Pharmacokinetic interaction study of indinavir/ritonavir and the enteric-coated capsule formulation of didanosine in healthy volunteers.
English: In addition, ddATP inhibits HIV-reverse transcriptase by competing with deoxyadenosine-triphosphate (dATP) for binding to the enzyme's active site, preventing proviral DNA synthesis.
Slovenian: Poleg tega ddATP zavre reverzno transkriptazo HIV, ker z deoksiadenozin-trifosfatom (dATP) tekmuje za vezavo na aktivno mesto encima, in tako prepreči sintezo provirusne DNK.
English: In the fed study, the results were satisfactory in terms of extent of absorption (i.e. AUC) with 90% CI within standard range of 80.00 - 125.00%.
Slovenian: V študiji pri zaužitju po obroku so bili rezultati glede obsega absorpcije (tj. AUC) zadovoljivi, z 90odstotnim intervalom zaupanja znotraj standardnega razpona 80,00-125,00 %.
English: Relationship between dideoxyinosine exposure, CD4 counts and p24 antigen levels in HIV infection.
Slovenian: 6 Drusano GL et al. Relationship between dideoxyinosine exposure, CD4 counts and p24 antigen levels in HIV infection.
English: Hence, both test and reference products can be considered as having similar food effect in terms of reduction in Cmax and AUC.
Slovenian: Zato je mogoče za testno in tudi za referenčno zdravilo zaključiti, da obstaja pri obeh podoben vpliv hrane kar zadeva zmanjšanje vrednosti Cmax in AUC.
English: The bioequivalence studies confirmed that dose dumping did not occur with Didanosine and associated names.
Slovenian: Študije biološke enakovrednosti so potrdile, da pri zdravilu Didanosine in povezanih imenih ni prišlo do sprostitve celotnega odmerka naenkrat.
English: The fed study was conducted during an extended clock-stop.
Slovenian: Študija pri zaužitju po obroku je bila izvedena med podaljšanim obdobjem od napotitve na zdravljenje do prvega prejetega dokončnega zdravljenja.
English: The results were satisfactory in terms of extent of absorption (i.e. AUC).
Slovenian: Kar zadeva obseg absorpcije (tj. vrednost AUC) so bili rezultati zadovoljivi.
English: The primary pharmacokinetic parameters (Cmax and AUC) were satisfactory in the fasting study with the 90% confidence interval (CI) falling within the standard criteria of 80.00 - 125.00%.
Slovenian: Rezultati študij biološke enakovrednosti V študiji pri zaužitju na tešče so bili primarni farmakokinetični parametri (Cmax in AUC) zadovoljivi, z 90-odstotnim intervalom zaupanja znotraj standardnih meril 80,00-125,00 %.
English: Therefore, for both the test and the reference product in the fed state the absorption of didanosine decreases which indicate that both products possess similar food effect in terms of reduction in Cmax and AUC with no evidence of dose-dumping.
Slovenian: Absorpcija didanozina se zato pri testnem in tudi pri referenčnem zdravilu pri zaužitju po obroku zmanjša, kar označuje, da je vpliv hrane pri obeh zdravilih podoben kar zadeva zmanjšanje vrednosti Cmax in AUC brez dokaza o sprostitvi celotnega odmerka naenkrat.
English: Patients on HAART Containing Didanosine Enteric-Coated Capsules (FOODDIe Study).
Slovenian: A Cohort Study of the Food Effect on Virological Failure and Treatment Discontinuation in Patients on HAART Containing Didanosine Enteric-Coated Capsules (FOODDIe Study).
English: In the current application, the AUC under both fasted and fed conditions was within the acceptance criteria of 80
Slovenian: V trenutni vlogi je bila vrednost AUC pri zaužitju na tešče in tudi pri zaužitju po obroku znotraj meril sprejemljivosti 80−125 %.
English: 2002b; 42:791-797 Beltangady M et al.
Slovenian: 2002b; 42:791-797 5 Beltangady M et al. Relation between plasma concentrations of didanosine and markers of antiviral efficacy in adults with AIDS and AIDS related complex.
English: Pharmaceutical Form Route of Administration
Slovenian: Številka EU Izmišljeno ime jakost farmacevtska oblika pot uporabe ovojnina vsebina (koncentracija) velikost pakiranja
English: This summary was last updated in 10-2007.
Slovenian: Ta povzetek je bil nazadnje posodobljen 10-2007.
English: The European Commission granted a marketing authorisation valid throughout the EU for Velosulin to Novo Nordisk A/S on 7 October 2002.
Slovenian: Evropska Komisija je dovoljenje za promet z zdravilom Velosulin, veljavno po vsej Evropski uniji, odobrila družbi Novo Nordisk A/S dne 7. oktobra 2002.
English: Other information about Velosulin:
Slovenian: Druge informacije o zdravilu Velosulin:
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) VELOSULIN EPAR summary for the public
Slovenian: EVROPSKO JAVNO POROČILO O OCENI ZDRAVILA (EPAR) VELOSULIN Povzetek EPAR za javnost
English: By controlling the blood glucose, the symptoms and complications of diabetes are reduced.
Slovenian: Z nadzorovanjem sladkorja v krvi se zmanjšajo simptomi in zapleti, povezani s sladkorno boleznijo.
English: What benefit has Velosulin shown during the studies?
Slovenian: Kakšne koristi je zdravilo Velosulin izkazalo med raziskavami?
English: Velosulin was effective for both type 1 and type 2 diabetes.
Slovenian: Zdravilo Velosulin se je izkazalo za učinkovito tako pri sladkorni bolezni tipa 1 kot tudi tipa 2.
English: The Committee for Medicinal products for Human Use (CHMP) decided that Velosulin's benefits are greater than its risks for the treatment of diabetes.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) je odločil, da so koristi zdravila Velosulin pri zdravljenju sladkorne bolezni večje od z njim povezanih tveganj.
English: What is the risk associated with Velosulin?
Slovenian: Kakšna tveganja so povezana z zdravilom Velosulin?
English: The studies measured the level of fasting blood sugar or a substance in the blood called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
Slovenian: V raziskavah so merili raven sladkorja v krvi na tešče ali tiste snovi v krvi (glikoziliranega hemoglobina, HbA1c), ki kaže, kako dobro je raven sladkorja v krvi nadzorovana.
English: Velosulin should not be used in people who may be hypersensitive (allergic) to insulin human (rDNA) or to any of the other ingredients.
Slovenian: Zdravila Velosulin ne smejo uporabljati osebe, ki utegnejo biti preobčutljive za (alergične na) humani insulin (rDNA) ali katerokoli drugo sestavino zdravila.
English: The studies used to support Velosulin are those that have been used to support Actrapid, another insulin approved in the European Union (EU).
Slovenian: Raziskave, ki so podprle uporabo zdravila Velosulin so iste kot za podporo uporabi zdravila Actrapid, še enega insulina, ki je odobren v EU.
English: The replacement insulin acts in same way as naturally produced insulin and helps glucose to enter cells from the blood.
Slovenian: Nadomestni insulin deluje na enak način kot naravno proizveden insulin, ter omogoča, da lahko glukoza vstopi iz krvi v celico.
English: Diabetes is a disease in which the body does not produce enough insulin to control the blood glucose.
Slovenian: Sladkorna bolezen je bolezen, pri kateri telo ne tvori dovolj insulina za uravnavanje sladkorja v krvi.
English: Velosulin is used to treat patients with diabetes.
Slovenian: Velosulin se uporablja za zdravljenje sladkorne bolezni.
English: The Committee recommended that Velosulin be given marketing authorisation.
Slovenian: Zato je priporočil, da se za zdravilo Velosulin podeli dovoljenje za promet z zdravilom.
English: Velosulin has also been studied used in an insulin pump.
Slovenian: Zdravilo Velosulin je bilo raziskano tudi uporabljeno v insulinski črpalki.
English: Why has Velosulin been approved?
Slovenian: Zakaj je bilo zdravilo Velosulin odobreno?
English: Velosulin led to a decrease in the level of HbA1c, indicating that blood glucose levels had been controlled to a similar level to that seen with the other human insulin.
Slovenian: Z uporabo zdravila Velosulin se je znižala raven HbA1c, kar kaže na to, da je bila raven sladkorja v krvi vzdrževana na podobnih ravneh kot pri uporabi drugih vrst humanega insulina.
English: Velosulin is a replacement insulin that is identical to the insulin made by the pancreas.
Slovenian: Velosulin je nadomestni insulin, ki je enak insulinu, ki ga proizvaja trebušna slinavka.
English: As with all insulins, Velosulin may cause hypoglycaemia (low blood glucose).
Slovenian: Zdravilo Velosulin lahko povzroči hipoglikemijo (nizko raven glukoze v krvi).
English: Velosulin is intended for continuous subcutaneous infusion (under the skin) using an insulin infusion pump.
Slovenian: Zdravilo Velosulin je namenjeno za stalno subkutano (podkožno) infuzijo z uporabo insulinske infuzijske črpalke.
English: The solution of insulin in Velosulin is specially prepared to make it stable for the duration of administration in an infusion pump.
Slovenian: Raztopina insulina v zdravilu Velosulin je pripravljena tako, da ostane stabilna ves čas trajanja dajanja v infuzijski črpalki.
English: Velosulin may also be injected into a vein or given subcutaneously by injection.
Slovenian: Velosulin je mogoče dati tudi v intravenski ali subkutani injekciji.
English: The full EPAR for Velosulin is available here.
Slovenian: Celotno Evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Velosulin je na voljo tukaj.
English: Velosulin is a fast-acting insulin and may be used with longer-acting insulin products.
Slovenian: Velosulin je hitrodelujoč insulin in se lahko uporablja v kombinaciji z insulinom z daljšim delovanjem.
English: The patient's blood glucose (sugar) should be tested regularly to find the lowest effective dose.
Slovenian: Za določitev najnižjega učinkovitega odmerka je potrebno redno spremljati raven sladkorja v krvi bolnika.
English: It contains the active substance insulin human (rDNA).
Slovenian: Zdravilo Velosulin vsebuje zdravilno učinkovino humani insulin (rDNA).
English: For the full list of all side effects reported with Velosulin, see the Package Leaflet.
Slovenian: Celovit opis neželenih učinkov, o katerih so poročali pri uporabi zdravila Velosulin, najdete v Navodilih za uporabo.
English: What is Velosulin used for?
Slovenian: Za kaj se zdravilo Velosulin uporablja?
English: What is Velosulin?
Slovenian: Kaj je zdravilo Velosulin?
English: How has Velosulin been studied?
Slovenian: Kako je bilo zdravilo Velosulin raziskano?
English: Velosulin doses might also need to be adjusted when given with a number of other medicines which may have an effect on blood glucose.
Slovenian: Odmerke zdravila Velosulin bo morda potrebno prilagoditi, če se zdravilo jemlje istočasno z drugimi zdravili, ki lahko vplivajo na koncentracijo sladkorja v krvi (celoten seznam le-teh najdete v Navodilih za uporabo).
English: How does Velosulin work?
Slovenian: Kako zdravilo Velosulin deluje?
English: The active substance in Velosulin, insulin human (rDNA), is produced by a method known as ‘recombinant DNA technology': the insulin is made by a yeast that has received a gene (DNA), which makes it able to produce insulin.
Slovenian: Zdravilna učinkovina zdravila Velosulin je humani insulin (rDNA), izdelan z metodo, imenovano „rekombinantna tehnologija“.
English: How is Velosulin used?
Slovenian: Kako se zdravilo Velosulin uporablja?
English: Velosulin is a solution for injection or infusion (drip).
Slovenian: Velosulin je bistra, brezbarvna raztopina insulina za injiciranje ali infundiranje v viali.
English: They should both have the same colour.
Slovenian: Oba morata biti iste barve.
English: Date of first authorisation: 16 September 2003 Date of latest renewal: 26 August 2013
Slovenian: Datum prve odobritve: 16. september 2003 Datum zadnjega podaljšanja: 26. avgust 2013
English: * Life-threatening and/or fatal cases have been reported.
Slovenian: * Poročali so o življenjsko ogrožajočih in/ali smrtnih primerih.
English: Do not drive or operate any tools or machines if you feel these effects.
Slovenian: Ne vozite in ne upravljajte orodij ali strojev, če občutite te učinke.
English: A specific antidote is not known.
Slovenian: Specifični antidot ni znan.
English: Do not use a facial mask.
Slovenian: Ne uporabljajte maske za obraz.
English: This dose should be maintained.
Slovenian: Ta odmerek je treba vzdrževati.
English: Tell your doctor if you are taking:
Slovenian: Obvestite zdravnika, če jemljete:
English: Your blood pressure may drop much further.
Slovenian: Vaš krvni tlak se lahko še dodatno zniža.
English: If it does, rinse the skin or your eyes immediately with plenty of water.
Slovenian: Če se to zgodi, kožo ali oči takoj sperite z večjo količino vode.
English: No unchanged substance is eliminated.
Slovenian: nespremenjeni obliki se ne izloča.
English: The following information is intended for healthcare professionals only: Instructions for use and handling
Slovenian: Naslednje informacije so namenjene samo zdravstvenemu osebju: Navodila za pripravo in ravnanje z zdravilom
English: Tell your doctor if they get worse.
Slovenian: Obvestite zdravnika, če se stanje poslabša.
English: System organ class (MedDRA)
Slovenian: Organski sistem (MedDRA)
English: Two programmes can be operated:
Slovenian: Na voljo sta dva programa:
English: In this case talk to your doctor immediately.
Slovenian: V tem primeru se takoj posvetujte z zdravnikom.
English: No data from controlled clinical trials are available.
Slovenian: Na voljo ni podatkov iz nadzorovanih kliničnih preskušanj.
English: 3 minutes
Slovenian: 3 minute
English: Component of a multipack, can't be sold separately.
Slovenian: Sestavni deli večkratnega pakiranja se ne morejo prodajati ločeno.
English: The duration of treatment depends on clinical status and is left to the physician's discretion.
Slovenian: Trajanje zdravljenja je odvisno od kliničnega stanja in je prepuščeno presoji zdravnika.
English: These concentrations decline with half-lives between approximately 5 and 25 minutes.
Slovenian: Te koncentracije padajo z razpolovnim časom približno 5 do 25 minut.
English: Your doctor will monitor you carefully.
Slovenian: Zdravnik vas bo skrbno spremljal.
English: How to inhale
Slovenian: Kako inhalirati
English: Elderly Pharmacokinetics in elderly patients have not been investigated.
Slovenian: Farmakokinetike pri starejših bolnikih niso preučevali.
English: In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.
Slovenian: Zaradi pomanjkanja študij kompatibilnosti zdravila se ga ne sme mešati z drugimi zdravili.
English: He/she will look for the cause and take appropriate measures.
Slovenian: Pregledal vas bo, da bi ugotovil vzroke težav in ustrezno ukrepal.
English: PPH is a category of pulmonary hypertension where the cause of the high blood pressure is not known.
Slovenian: PPH je kategorija pljučne hipertenzije, pri kateri vzrok visokega krvnega tlaka ni znan.
English: Do not use this medicine after the expiry date which is stated on the carton and ampoule.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in ampuli.
English: The safety and efficacy of Ventavis in children aged up to 18 years have not been established.
Slovenian: Varnost in učinkovitost zdravila Ventavis pri otrocih, starih do 18 let, nista bili dokazani.
English: Your doctor will monitor you and treat any resulting symptoms.
Slovenian: Zdravnik vas bo spremljal in zdravil morebitne simptome.
English: Bayer Austria Ges.
Slovenian: Österreich Bayer Austria Ges.
English: Stand up slowly when you get out of chairs or bed.
Slovenian: S stola ali iz postelje vstajajte počasi.
English: The active substance can be delivered more rapidly to your lungs.
Slovenian: Učinkovina se lahko hitreje dovede v vaša pljuča.
English: Systemic toxicity
Slovenian: Sistemska toksičnost
English: When using the I-Neb AAD system the following instructions need to be followed.
Slovenian: Pri uporabi nebulatorja I-Neb AAD je treba slediti naslednjim navodilom.
English: You should continue on this dose.
Slovenian: Nadaljevati morate s tem odmerkom.
English: Not known (cannot be estimated from the available data)
Slovenian: neznana (ni mogoče oceniti iz razpoložljivih podatkov)
English: If you tend to faint as soon as you get out of bed, it may be helpful to take your first dose of the day while you are still lying down.
Slovenian: Če ste nagnjeni k omedlevicam, takoj ko vstanete iz postelje, vam bo morda pomagalo, če vzamete svoj prvi dnevni odmerek, ko še ležite.
English: Ventavis and certain other medicines may affect each other in the way they work in your body.
Slovenian: Zdravilo Ventavis in nekatera druga zdravila lahko v vašem telesu vplivajo druga na drugo.
English: No reliable conclusion could be drawn on efficacy of the association as the sample size was limited and the study was of short duration.
Slovenian: Zanesljivih zaključkov glede učinkovitosti ni, ker je bil vzorec premajhen in je preskušanje trajalo prekratek čas.
English: Ventavis with food and drink
Slovenian: Zdravilo Ventavis skupaj s hrano in pijačo
English: • Fainting episodes may be due to the underlying disease.
Slovenian: • Pogoste omedlevice so lahko posledica osnovne bolezni.
English: To avoid undesired accumulation over the day, special caution has to be exercised with these patients during initial dose titration.
Slovenian: Da bi se izognili neželenemu kopičenju zdravila tekom dneva, je pri teh bolnikih potrebna posebna previdnost pri titraciji začetnega odmerka.
English: Bayer AG 51368 Leverkusen Germany
Slovenian: Bayer AG 51368 Leverkusen
English: If you feel that the effect of Ventavis is too strong or too weak, talk to your doctor or pharmacist.
Slovenian: Če menite, da je učinek zdravila Ventavis premočan ali prešibak, se posvetujte z zdravnikom ali farmacevtom.
English: • The active substance is iloprost.
Slovenian: • Učinkovina je iloprost.
English: The following serious side effects may occur.
Slovenian: Pojavijo se lahko naslednji resni neželeni učinki.
English: § see section “Description of selected adverse reactions”
Slovenian: § glejte poglavje »Opis izbranih neželenih učinkov«
English: Cases of overdose were reported.
Slovenian: Simptomi Poročali so o primerih prevelikega odmerjanja.
English: However, the predictive value of these acute haemodynamic data are considered to be of limited value as acute response does not in all cases correlate with long-term benefit of treatment with inhaled iloprost.
Slovenian: Kljub temu pa je napovedna vrednost teh akutnih hemodinamičnih podatkov omejena, ker akutni odziv v vseh primerih ni sorazmeren z dolgoročno koristnostjo zdravljenja z inhalacijami iloprosta.
English: Multipacks containing:
Slovenian: Večkratno pakiranje vsebuje:
English: Improved blood flow leads to a better supply of oxygen to the body and reduced strain on the heart.
Slovenian: Izboljšan pretok krvi povzroči boljšo oskrbo telesa s kisikom in zmanjšano obremenitev srca.
English: There are two different colour coded medication chambers.
Slovenian: Obstajata dva z različnima barvama označena prostora za zdravilo.
English: Pharmacokinetics after use with different nebulisers
Slovenian: Farmakokinetika pri uporabi različnih nebulatorjev
English: The frequencies of adverse reactions are defined as very common (≥1/10) and common (≥1/100 to <1/10).
Slovenian: Pogostnost neželenih učinkov je opredeljena kot zelo pogosti (≥ 1/10) in pogosti (≥ 1/100 do < 1/10).
English: Interruption of the inhalation session, monitoring and symptomatic measures are recommended.
Slovenian: Priporoča se prekinitev inhalacije, spremljanje in simptomatsko zdravljenje.
English: The main metabolite is tetranor-iloprost, which is found in the urine in free and conjugated form.
Slovenian: Glavni presnovek je tetranor-iloprost, ki se v seču nahaja v prosti in konjugirani obliki.
English: • anticoagulants, such as heparin, oral anticoagulants (either coumarin-type or direct),
Slovenian: • antikoagulanti, kot so heparin, peroralni antikoagulanti (bodisi kumarini ali neposredni antikoagulanti),
English: If you swallow it accidentally, drink plenty of water and tell your doctor.
Slovenian: Če bi jo po nesreči popili, spijte večjo količino vode in se posvetujte z zdravnikom.
English: Not known: frequency cannot be estimated from the available data.
Slovenian: Neznana: pogostnosti ni mogoče oceniti iz razpoložljivih podatkov
English: Ventavis should not be initiated in patients with systolic blood pressure less than 85 mmHg.
Slovenian: Zdravila Ventavis se ne sme uvesti pri bolnikih s sistoličnim krvnim tlakom, nižjim od 85 mmHg.
English: • if you are allergic to iloprost or any of the other ingredients of this medicine (listed in section 6),
Slovenian: • če ste alergični na iloprost ali katero koli sestavino tega zdravila (navedeno v poglavju 6),
English: The adverse reactions identified only during post-marketing surveillance, and for which a frequency could not be estimated from clinical trial data, are listed under "Frequency not known".
Slovenian: Neželeni učinki, ugotovljeni samo v obdobju trženja in za katere pogostnosti ni mogoče oceniti na podlagi podatkov iz kliničnih preskušanj, so navedeni kot »neznana«.
English: The acute adverse effects in patients receiving concomitant bosentan and iloprost were consistent with those observed in the larger experience of the phase 3 study in patients receiving only iloprost.
Slovenian: Akutni neželeni učinki pri bolnikih, ki so sočasno prejemali bosentan in iloprost, so bili enaki tistim, ki so jih opazili v večji študiji III. faze pri bolnikih, ki so prejemali samo iloprost.
English: In clinical trials peripheral oedema was reported in 12.2% of patients on iloprost and 16.2% of patients on placebo.
Slovenian: V kliničnih preskušanjih so poročali o perifernem edemu pri 12,2 % bolnikov, ki so prejemali iloprost, in pri 16,2 % bolnikov, ki so prejemali placebo.
English: Invasive haemodynamic parameters were assessed at baseline and after 12 weeks treatment.
Slovenian: Invazivni hemodinamični dejavniki so bili ocenjeni na začetku in po 12 tednih zdravljenja.
English: Ventavis is used to improve exercise capacity (the ability to carry out physical activity) and symptoms.
Slovenian: Zdravilo Ventavis se uporablja za izboljšanje telesnih sposobnosti (zmožnosti opravljanja fizičnih aktivnosti) in lajšanje simptomov.
English: Control disc
Slovenian: Nadzorni disk